 This study has identified two monoclonal antibodies that can neutralize the SARS-CoV-2 virus. The antibodies were derived from B-cells of recovered COVID-19 patients and are capable of reducing viral load in blood, kidneys, and brains. Further research is needed to determine if the antibodies can be used to treat COVID-19 patients. This article was authored by Chattacorn Bonkrai, Thomas S. Cottron, watch it upon Shesurion, and others.